Literature DB >> 17380405

Comparison of the secretin stimulated endoscopic pancreatic function test to retrograde pancreatogram.

Darwin L Conwell1, Gregory Zuccaro, John J Vargo, John A Dumot, Frederick VanLente, Farah Khandwala, Patricia A Trolli, Cathy O'Laughlin.   

Abstract

Duodenal intubation techniques with hormonal stimulation are the most accurate at diagnosing early chronic pancreatitis. Pancreatography (ERCP), the radiologic gold standard, can accurately diagnose chronic pancreatitis, but is expensive, may expose the patient to radiation, and/or induce acute pancreatitis. We have developed an endoscopic pancreatic function test (ePFT) that can assess pancreatic secretory function during upper endoscopy. We sought to determine the accuracy of the endoscopic secretin pancreatic function test using retrograde pancreatogram as the gold standard. Patients referred to The Pancreas Clinic for the evaluation and management of chronic abdominal pain and suspected chronic pancreatitis who had both endoscopic function testing and pancreatic duct imaging (ERCP) were studied. Pancreatograms were scored for duct morphologic characteristics (Cambridge classification) and compared to peak bicarbonate concentration in secretin stimulated duodenal juice. The ePFT consisted of a test dose of intravenous synthetic porcine secretin (0.2 microg), full-dose intravenous secretin (0.2 microg/kg) over 1 min, (3) upper endoscopy with moderate sedation, (4) gastric fluid aspirated and discarded, (5) duodenal fluid aspirations at 0, 15, 45, and 60 min after secretin injection, and (6) fluid analysis with lab autoanalyzer for bicarbonate concentration (historical normal cutpoint >80 mEq/L). Thirty-six patients had both the endoscopic function test and ERCP. Seventeen had chronic abdominal pain with normal pancreatograms, and nineteen had chronic abdominal pain with abnormal pancreatograms, consistent with chronic pancreatitis. The sensitivity and specificity of the endoscopic function test were 94% and 79%, respectively. The positive and negative predictive values were 80% and 94%, respectively. Overall agreement with ERCP was 86%. The ePFT with synthetic porcine secretin has excellent correlation with abnormal pancreatogram (chronic pancreatitis). Furthermore, a normal bicarbonate (negative function test, HCO(3) >80 mEq/L) essentially rules out chronic pancreatitis as a diagnostic cause of abdominal pain. Endoscopic pancreatic function testing may decrease the need for ERCP in patients with chronic abdominal pain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380405     DOI: 10.1007/s10620-006-9600-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  10 in total

Review 1.  The diagnosis of chronic pancreatitis.

Authors:  C E Forsmark
Journal:  Gastrointest Endosc       Date:  2000-08       Impact factor: 9.427

2.  Studies in pancreatic function; preliminary series of clinical studies with the secretin test.

Authors:  D A DREILING; F HOLLANDER
Journal:  Gastroenterology       Date:  1948-11       Impact factor: 22.682

3.  Simultaneous measurements of total pancreatic, biliary, and gastric outputs in man using a perfusion technique.

Authors:  V L Go; A F Hofmann; W H Summerskill
Journal:  Gastroenterology       Date:  1970-03       Impact factor: 22.682

Review 4.  Chronic pancreatitis.

Authors:  M L Steer; I Waxman; S Freedman
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

5.  Standards for the diagnosis of chronic pancreatitis and for the evaluation of treatment.

Authors:  P G Lankisch; A Andrén-Sandberg
Journal:  Int J Pancreatol       Date:  1993-12

6.  On the biological assay of secretin. The reference standard.

Authors:  J E Jorpes; V Mutt
Journal:  Acta Physiol Scand       Date:  1966-03

7.  A double-blind, randomized, dose response study testing the pharmacological efficacy of synthetic porcine secretin.

Authors:  P S Jowell; G Robuck-Mangum; K Mergener; M S Branch; E D Purich; S H Fein
Journal:  Aliment Pharmacol Ther       Date:  2000-12       Impact factor: 8.171

8.  Synthetic porcine secretin is highly accurate in pancreatic function testing in individuals with chronic pancreatitis.

Authors:  L Somogyi; M Cintron; P P Toskes
Journal:  Pancreas       Date:  2000-10       Impact factor: 3.327

9.  An endoscopic pancreatic function test with synthetic porcine secretin for the evaluation of chronic abdominal pain and suspected chronic pancreatitis.

Authors:  Darwin L Conwell; Gregory Zuccaro; John J Vargo; Patricia A Trolli; Frederick Vanlente; Nancy Obuchowski; John A Dumot; Cathy O'laughlin
Journal:  Gastrointest Endosc       Date:  2003-01       Impact factor: 9.427

10.  An endoscopic pancreatic function test with cholecystokinin-octapeptide for the diagnosis of chronic pancreatitis.

Authors:  Darwin L Conwell; Gregory Zuccaro; John J Vargo; J Brad Morrow; Nancy Obuchowski; John A Dumot; Patricia A Trolli; Allison Burton; Cathy O'laughlin; Frederick Van Lente
Journal:  Clin Gastroenterol Hepatol       Date:  2003-05       Impact factor: 11.382

  10 in total
  1 in total

1.  Proteomic analysis (GeLC-MS/MS) of ePFT-collected pancreatic fluid in chronic pancreatitis.

Authors:  Joao A Paulo; Vivek Kadiyala; Linda S Lee; Peter A Banks; Darwin L Conwell; Hanno Steen
Journal:  J Proteome Res       Date:  2012-02-07       Impact factor: 4.466

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.